Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KENNETH G OLESZEK

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1902878291
CMS profile
559590
Location
DENVER, CO

General Payments · PY2018–2024

$71,966.82

  • Reported across 145 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,268.37

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Galderma Laboratories, L.P. $4,527.65 2
Acerta Pharma LLC $588.76 9
ABBVIE INC. $151.96 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $12,404.05 34
PY2019 $8,437.33 27
PY2020 $6,594.44 13
PY2021 $14,786.89 18
PY2022 $9,336.61 24
PY2023 $15,139.13 15
PY2024 $5,268.37 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $138.61 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105151609 CMS
ABBVIE INC. $7.20 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105151611 CMS
ABBVIE INC. $6.15 07/09/2024 Food and Beverage Undisputed 01/23/2026 1105151613 CMS
AstraZeneca Pharmaceuticals LP $104.42 01/01/2024 Food and Beverage Undisputed 01/23/2026 1104548472 CMS
AstraZeneca Pharmaceuticals LP $34.71 01/24/2024 Food and Beverage Undisputed 01/23/2026 1104376591 CMS
AstraZeneca Pharmaceuticals LP $44.43 01/26/2024 Food and Beverage Undisputed 01/23/2026 1104285175 CMS
AstraZeneca Pharmaceuticals LP $14.40 01/27/2024 Food and Beverage Undisputed 01/23/2026 1104218799 CMS
AstraZeneca Pharmaceuticals LP $122.88 01/27/2024 Food and Beverage Undisputed 01/23/2026 1105637588 CMS
AstraZeneca Pharmaceuticals LP $22.59 02/15/2024 Food and Beverage Undisputed 01/23/2026 1104563362 CMS
AstraZeneca Pharmaceuticals LP $122.02 02/15/2024 Food and Beverage Undisputed 01/23/2026 1105617779 CMS
AstraZeneca Pharmaceuticals LP $39.00 02/22/2024 Food and Beverage Undisputed 01/23/2026 1105606163 CMS
AstraZeneca Pharmaceuticals LP $84.31 03/17/2024 Food and Beverage Undisputed 01/23/2026 1104357873 CMS
Galderma Laboratories, L.P. $27.65 06/05/2024 Food and Beverage Undisputed 01/23/2026 1145319761 CMS
Galderma Laboratories, L.P. $4,500.00 07/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1145319763 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.